189 related articles for article (PubMed ID: 15627182)
1. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.
Amthauer H; Denecke T; Rohlfing T; Ruf J; Böhmig M; Gutberlet M; Plöckinger U; Felix R; Lemke AJ
Eur Radiol; 2005 Jul; 15(7):1456-62. PubMed ID: 15627182
[TBL] [Abstract][Full Text] [Related]
2. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
Castaldi P; Rufini V; Treglia G; Bruno I; Perotti G; Stifano G; Barbaro B; Giordano A
Radiol Med; 2008 Oct; 113(7):1056-67. PubMed ID: 18797822
[TBL] [Abstract][Full Text] [Related]
3. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
[TBL] [Abstract][Full Text] [Related]
4. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?
Amthauer H; Ruf J; Böhmig M; Lopez-Hänninen E; Rohlfing T; Wernecke KD; Plöckinger U; Gutberlet M; Lemke AJ; Steinmüller T; Wiedenmann B; Felix R
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):342-8. PubMed ID: 14652697
[TBL] [Abstract][Full Text] [Related]
6. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms.
Pfannenberg AC; Eschmann SM; Horger M; Lamberts R; Vonthein R; Claussen CD; Bares R
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):835-43. PubMed ID: 12682789
[TBL] [Abstract][Full Text] [Related]
7. Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis.
Ingui CJ; Shah NP; Oates ME
J Comput Assist Tomogr; 2007; 31(3):375-80. PubMed ID: 17538282
[TBL] [Abstract][Full Text] [Related]
8. Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.
Perri M; Erba P; Volterrani D; Lazzeri E; Boni G; Grosso M; Mariani G
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):323-33. PubMed ID: 18480741
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Van Binnebeek S; Vanbilloen B; Baete K; Terwinghe C; Koole M; Mottaghy FM; Clement PM; Mortelmans L; Bogaerts K; Haustermans K; Nackaerts K; Van Cutsem E; Verslype C; Verbruggen A; Deroose CM
Eur Radiol; 2016 Mar; 26(3):900-9. PubMed ID: 26162577
[TBL] [Abstract][Full Text] [Related]
10. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.
Utsunomiya D; Shiraishi S; Imuta M; Tomiguchi S; Kawanaka K; Morishita S; Awai K; Yamashita Y
Radiology; 2006 Jan; 238(1):264-71. PubMed ID: 16304081
[TBL] [Abstract][Full Text] [Related]
11. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Pérault C; Schvartz C; Wampach H; Liehn JC; Delisle MJ
J Nucl Med; 1997 Aug; 38(8):1234-42. PubMed ID: 9255157
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of
Trogrlic M; Težak S
Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
14. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
[TBL] [Abstract][Full Text] [Related]
15. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma.
Ruf J; Lehmkuhl L; Bertram H; Sandrock D; Amthauer H; Humplik B; Ludwig Munz D; Felix R
Nucl Med Commun; 2004 Dec; 25(12):1177-82. PubMed ID: 15640775
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Asphericity in Pretherapeutic [
Wetz C; Apostolova I; Steffen IG; Hofheinz F; Furth C; Kupitz D; Ruf J; Venerito M; Klose S; Amthauer H
Mol Imaging Biol; 2017 Jun; 19(3):437-445. PubMed ID: 27743210
[TBL] [Abstract][Full Text] [Related]
17. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
Frilling A; Malago M; Martin H; Broelsch CE
Surgery; 1998 Dec; 124(6):1000-4. PubMed ID: 9854575
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
[TBL] [Abstract][Full Text] [Related]
19. The value of preoperative imaging in small bowel neuroendocrine tumors.
Dahdaleh FS; Lorenzen A; Rajput M; Carr JC; Liao J; Menda Y; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2013 Jun; 20(6):1912-7. PubMed ID: 23283442
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hybrid
Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
